Related Experiment Video

Updated: Jun 22, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.1K

Antibody-drug conjugates combinations in cancer treatment

Giulia Pretelli1, Kleida Mati2, Lucia Motta3,4

  • 1Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain.

Exploration of Targeted Anti-Tumor Therapy
|July 5, 2024
PubMed

Insights

Antibody-drug conjugates (ADCs) show promise in cancer treatment but face challenges. Combining ADCs with other therapies may improve outcomes and overcome resistance, representing a key area for future research.

Area of Science:

  • Oncology
  • Pharmacology
  • Biotechnology

Background:

  • Antibody-drug conjugates (ADCs) are a significant class of anticancer agents.
  • While 12 ADCs are FDA-approved, 2 have been withdrawn, and many are in clinical development.
  • ADCs demonstrate antitumoral activity but present challenges with adverse events and resistance.

Purpose of the Study:

  • To review current combinations of ADCs with other antitumor agents.
  • To describe the state-of-the-art in ADC combination therapies.
  • To outline future directions for ADC combination strategies.

Main Methods:

  • Literature review of clinical trials and preclinical studies.
  • Analysis of combination therapies involving ADCs and agents like chemotherapy, immune checkpoint inhibitors, monoclonal antibodies, and targeted agents.
  • Synthesis of data on efficacy, safety, and resistance mechanisms.

Main Results:

  • Combinations of ADCs with other anticancer agents are being actively investigated in numerous clinical trials.
  • Promising results indicate potential synergistic effects and improved treatment outcomes across various tumor types.
  • Current research highlights the potential of combination therapies to enhance ADC efficacy and manage resistance.

Conclusions:

  • ADC combination therapies represent a rapidly evolving field with significant therapeutic potential.
  • Further research is needed to optimize combination strategies and overcome clinical challenges.
  • Future directions include exploring novel combinations and personalized treatment approaches for enhanced cancer therapy.
Keywords:
Antibody-drug conjugatescancer treatmentcombination regimensnovel anticancer therapies

More Related Videos

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

7.6K
Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

7.8K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K